Go Pro
→ Nvidia's CEO says this small device is critical for AI growth (From Brownstone Research) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bioventus Inc. stock logo
BVS
Bioventus
$13.98
-8.4%		$10.59
$6.26
▼
$15.89
$1.17B0.63529,957 shs1.52 million shs
iRadimed Corporation stock logo
IRMD
iRadimed
$91.21
-0.7%		$94.53
$67.51
▼
$107.90
$1.17B0.9108,907 shs94,438 shs
STAAR Surgical Company stock logo
STAA
STAAR Surgical
$23.12
+1.1%		$27.43
$15.59
▼
$35.87
$1.15B1.261.20 million shs725,564 shs
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
$4.38
-8.4%		$4.13
$1.17
▼
$7.78
$284.14M1.37766,442 shs667,087 shs
Options Trading Made Easy - Download Now Cover
Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bioventus Inc. stock logo
BVS
Bioventus
+13.71%+16.31%+29.54%+43.29%+148.53%
iRadimed Corporation stock logo
IRMD
iRadimed
-1.36%-2.60%-10.21%+5.90%+32.04%
STAAR Surgical Company stock logo
STAA
STAAR Surgical
-5.22%-4.23%-16.39%-16.20%-15.40%
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
+0.84%+18.32%+4.82%+148.96%-14.49%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bioventus Inc. stock logo
BVS
Bioventus
$13.98
-8.4%		$10.59
$6.26
▼
$15.89
$1.17B0.63529,957 shs1.52 million shs
iRadimed Corporation stock logo
IRMD
iRadimed
$91.21
-0.7%		$94.53
$67.51
▼
$107.90
$1.17B0.9108,907 shs94,438 shs
STAAR Surgical Company stock logo
STAA
STAAR Surgical
$23.12
+1.1%		$27.43
$15.59
▼
$35.87
$1.15B1.261.20 million shs725,564 shs
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
$4.38
-8.4%		$4.13
$1.17
▼
$7.78
$284.14M1.37766,442 shs667,087 shs
Options Trading Made Easy - Download Now Cover
Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bioventus Inc. stock logo
BVS
Bioventus
+13.71%+16.31%+29.54%+43.29%+148.53%
iRadimed Corporation stock logo
IRMD
iRadimed
-1.36%-2.60%-10.21%+5.90%+32.04%
STAAR Surgical Company stock logo
STAA
STAAR Surgical
-5.22%-4.23%-16.39%-16.20%-15.40%
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
+0.84%+18.32%+4.82%+148.96%-14.49%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bioventus Inc. stock logo
BVS
Bioventus
3.00
Buy$16.2516.24% Upside
iRadimed Corporation stock logo
IRMD
iRadimed
2.80
Moderate Buy$120.0031.56% Upside
STAAR Surgical Company stock logo
STAA
STAAR Surgical
2.15
Hold$26.9416.54% Upside
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
1.86
Reduce$4.9713.47% Upside

Current Analyst Ratings Breakdown

Latest TMCI, STAA, IRMD, and BVS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/6/2026
Bioventus Inc. stock logo
BVS
Bioventus
Craig Hallum logo
Craig Hallum
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$18.00
8/6/2026
Bioventus Inc. stock logo
BVS
Bioventus
Barrington Research logo
Barrington Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$18.00
8/4/2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
8/4/2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
Wedbush logo
Wedbush
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform$40.00
8/3/2026
iRadimed Corporation stock logo
IRMD
iRadimed
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy (B-) ➝ Hold (C+)
7/28/2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageSell$20.00
7/22/2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
Wedbush logo
Wedbush
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform$40.00
7/16/2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
Wedbush logo
Wedbush
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform$40.00
7/16/2026
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetHold$2.00 ➝ $4.00
6/30/2026
Bioventus Inc. stock logo
BVS
Bioventus
Barrington Research logo
Barrington Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform$14.00
6/25/2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
(Data available from 8/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bioventus Inc. stock logo
BVS
Bioventus
$568.09M2.06$1.33 per share10.52$2.76 per share5.07
iRadimed Corporation stock logo
IRMD
iRadimed
$83.81M13.92$1.82 per share50.10$7.96 per share11.46
STAAR Surgical Company stock logo
STAA
STAAR Surgical
$290.38M3.96N/AN/A$6.92 per share3.34
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
$207.32M1.37N/AN/A$1.37 per share3.20
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bioventus Inc. stock logo
BVS
Bioventus
$22.73M$0.4134.1015.711.714.94%29.97%9.52%N/A
iRadimed Corporation stock logo
IRMD
iRadimed
$22.48M$1.7950.96N/AN/A26.70%23.45%20.36%N/A
STAAR Surgical Company stock logo
STAA
STAAR Surgical
-$80.45M-$0.43N/A77.07N/A-7.24%3.31%2.55%8/12/2026 (Estimated)
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
-$59M-$0.97N/AN/AN/A-29.44%-67.04%-30.28%8/7/2026 (Estimated)

Latest TMCI, STAA, IRMD, and BVS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2026Q2 2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
$0.21N/AN/AN/A$90.59 millionN/A
8/7/2026Q2 2026
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
-$0.30N/AN/AN/A$44.02 millionN/A
8/5/2026Q2 2026
Bioventus Inc. stock logo
BVS
Bioventus
$0.22$0.22N/A$0.47N/A$153.21 million
7/31/2026Q2 2026
iRadimed Corporation stock logo
IRMD
iRadimed
$0.44$0.46+$0.02$0.41$20.35 million$20.47 million
5/13/2026Q1 2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
$0.0542$0.10+$0.0458$0.10$78.72 million$93.52 million
5/8/2026Q1 2026
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
-$0.31-$0.28+$0.03-$0.28$45.96 million$47.20 million
5/6/2026Q1 2026
Bioventus Inc. stock logo
BVS
Bioventus
$0.09$0.15+$0.06$0.04N/A$132.09 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Bioventus Inc. stock logo
BVS
Bioventus
N/AN/AN/AN/AN/A
iRadimed Corporation stock logo
IRMD
iRadimed
$0.800.88%N/A44.69%1 Years
STAAR Surgical Company stock logo
STAA
STAAR Surgical
N/AN/AN/AN/AN/A
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
N/AN/AN/AN/AN/A

Latest TMCI, STAA, IRMD, and BVS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/30/2026
iRadimed Corporation stock logo
IRMD
iRadimed
quarterly$0.200.88%8/14/20268/14/20268/28/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bioventus Inc. stock logo
BVS
Bioventus
1.08
1.69
1.13
iRadimed Corporation stock logo
IRMD
iRadimed
N/A
9.46
6.15
STAAR Surgical Company stock logo
STAA
STAAR Surgical
0.09
5.12
4.31
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
0.72
3.58
2.53

Institutional Ownership

CompanyInstitutional Ownership
Bioventus Inc. stock logo
BVS
Bioventus
62.94%
iRadimed Corporation stock logo
IRMD
iRadimed
92.34%
STAAR Surgical Company stock logo
STAA
STAAR Surgical
96.70%
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
84.08%

Insider Ownership

CompanyInsider Ownership
Bioventus Inc. stock logo
BVS
Bioventus
33.50%
iRadimed Corporation stock logo
IRMD
iRadimed
34.60%
STAAR Surgical Company stock logo
STAA
STAAR Surgical
39.90%
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
23.42%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bioventus Inc. stock logo
BVS
Bioventus
1,20083.54 million55.55 millionN/A
iRadimed Corporation stock logo
IRMD
iRadimed
11012.79 million8.36 millionOptionable
STAAR Surgical Company stock logo
STAA
STAAR Surgical
1,21149.79 million29.92 millionOptionable
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
25064.87 million49.68 millionOptionable

Recent News About These Companies

Treace Medical Concepts (TMCI) to Release Quarterly Earnings on Friday
July 31, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30931233
Treace Medical Concepts (TMCI) Expected to Post Earnings on Friday
July 31, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/treace-medical-concepts-tmci-expected-to-post-earnings-on-friday-2026-07-31/
Did Treace Medical Concepts, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
July 24, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/did-treace-medical-concepts-inc-insiders-breach-their-fiduciary-duties-to-shareholders-302834260.html
Treace to Report Second Quarter 2026 Financial Results on August 7, 2026
July 24, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/24/3332779/0/en/treace-to-report-second-quarter-2026-financial-results-on-august-7-2026.html
Why Treace Medical Concepts, Inc.’s (TMCI) Stock Is Down 5.42%
July 23, 2026  |  aaii.comA
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Consensus Recommendation of "Reduce" from Brokerages
July 17, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/treace-medical-concepts-inc-nasdaqtmci-receives-consensus-recommendation-of-reduce-from-brokerages-2026-07-17/
Treace Medical Concepts (NASDAQ:TMCI) Given New $4.00 Price Target at Truist Financial
July 16, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/treace-medical-concepts-nasdaqtmci-given-new-400-price-target-at-truist-financial-2026-07-16/
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Short Interest Down 46.6% in June
July 15, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/treace-medical-concepts-inc-nasdaqtmci-short-interest-down-466-in-june-2026-07-15/
Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Treace Medical Concepts, Inc. (TMCI)
July 13, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/13/3326260/0/en/Johnson-Fistel-PLLP-Investigates-Claims-on-Behalf-of-Long-Term-Shareholders-of-Treace-Medical-Concepts-Inc-TMCI.html
TMCI Share News Today
June 30, 2026  |  uk.investing.comhttps://uk.investing.com/equities/treace-medical-concepts-news/11
Treace Announces First Surgical Case with the HyperPlate™ XM Dynamic Compression Locking Implant System
June 18, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/18/3314065/0/en/treace-announces-first-surgical-case-with-the-hyperplate-xm-dynamic-compression-locking-implant-system.html
Treace Medical Concepts (NASDAQ:TMCI) CEO John Treace Buys 22,887 Shares
June 12, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-tmci-insider-buying-and-selling-2026-06-12/
Treace to Present at the Sidoti Small Cap Conference
June 11, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/11/3310787/0/en/treace-to-present-at-the-sidoti-small-cap-conference.html
Treace Medical Concepts (NASDAQ:TMCI) CEO John Treace Acquires 50,000 Shares
June 2, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-tmci-insider-buying-and-selling-2026-06-02/
Treace Medical Concepts Balances Growth With Earnings Strain
June 1, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/treace-medical-concepts-balances-growth-with-earnings-strain?utm_source=marketbeat.com&utm_medium=referral
John Treace Purchases 4,508 Shares of Treace Medical Concepts (NASDAQ:TMCI) Stock
May 29, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-tmci-insider-buying-and-selling-2026-05-29/
Treace Medical Shareholders Back Directors, Pay and Auditor
May 20, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/treace-medical-shareholders-back-directors-pay-and-auditor?utm_source=marketbeat.com&utm_medium=referral
Treace Medical Concepts, Inc.
May 15, 2026  |  edition.cnn.comhttps://edition.cnn.com/markets/stocks/TMCI
Treace Medical Concepts (NASDAQ:TMCI) CEO John Treace Buys 43,000 Shares
May 15, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-tmci-insider-buying-and-selling-2026-05-15/
Treace Medical Concepts, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
May 12, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/12/3292819/0/en/treace-medical-concepts-inc-shareholders-are-encouraged-to-reach-out-to-johnson-fistel-for-more-information-about-potentially-recovering-their-losses.html
Treace Medical Concepts Inc (TMCI) Q1 2026 Earnings Call Highlights: Navigating Revenue ...
May 9, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/sectors/healthcare/articles/treace-medical-concepts-inc-tmci-070245998.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Bioventus stock logo

Bioventus NASDAQ:BVS

$13.98 -1.28 (-8.39%)
Closing price 04:00 PM Eastern
Extended Trading
$13.69 -0.29 (-2.07%)
As of 04:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Bioventus Inc. a medical device company, focuses on developing and commercializing clinically treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's portfolio of products includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions include bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies comprise an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.

iRadimed stock logo

iRadimed NASDAQ:IRMD

$91.21 -0.65 (-0.71%)
Closing price 04:00 PM Eastern
Extended Trading
$91.57 +0.36 (+0.39%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.

STAAR Surgical stock logo

STAAR Surgical NASDAQ:STAA

$23.12 +0.26 (+1.14%)
Closing price 04:00 PM Eastern
Extended Trading
$23.10 -0.02 (-0.06%)
As of 04:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Treace Medical Concepts stock logo

Treace Medical Concepts NASDAQ:TMCI

$4.38 -0.40 (-8.37%)
Closing price 04:00 PM Eastern
Extended Trading
$4.39 +0.01 (+0.23%)
As of 04:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas